Amare Pharma Launches a New Expert Division — Amare Salute

Amare Pharma announces the launch of its new strategic division — Amare Salute, aimed at strengthening an expert-driven approach to the use of pharmaceutical products manufactured in South Korea.

The project’s key partner is the pharmaceutical manufacturer Unimed Pharm (South Korea) — a company operating within a strictly regulated clinical medicine segment and fully compliant with international quality standards.

Within Amare Salute, the company expands its presence in key therapeutic areas, including:

• Neurology
• Cardiology
• Endocrinology

The launch of this new division is aimed at advancing clinical expertise, raising standards in pharmaceutical practice, and strengthening trust within the professional medical community.

Amare Salute represents a new stage in the development of Amare Pharma, reflecting the company’s transition toward a higher level of scientific and clinical responsibility in collaboration with international partners. ** Under the leadership of Amare PharmCo, the project is shaping a modern approach to pharmaceutical solutions based on quality, evidence-based medicine, and global expertise.**